These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 7563854)

  • 1. [Immunohistochemical observation of Fas in the liver with chronic hepatitis C].
    Takatani M; Yamada G
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):667-74. PubMed ID: 7563854
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C.
    Hiramatsu N; Hayashi N; Katayama K; Mochizuki K; Kawanishi Y; Kasahara A; Fusamoto H; Kamada T
    Hepatology; 1994 Jun; 19(6):1354-9. PubMed ID: 7514559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunohistochemical observation of Fas in the liver of chronic hepatitis B and its ultrastructural localization].
    Takatani M; Yamada G
    Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):234-40. PubMed ID: 12442391
    [No Abstract]   [Full Text] [Related]  

  • 4. [Role of Fas system in apoptosis induced by hepatitis C virus infection].
    Mita E; Hayashi N; Kamada T
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):198-202. PubMed ID: 7563698
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma.
    El-Bassiouni A; Nosseir M; Zoheiry M; El-Ahwany E; Ghali A; El-Bassiouni N
    APMIS; 2006 Jun; 114(6):420-7. PubMed ID: 16856963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adiponectin inhibits steatotic CD95/Fas up-regulation by hepatocytes: therapeutic implications for hepatitis C.
    Wedemeyer I; Bechmann LP; Odenthal M; Jochum C; Marquitan G; Drebber U; Gerken G; Gieseler RK; Dienes HP; Canbay A
    J Hepatol; 2009 Jan; 50(1):140-9. PubMed ID: 19019483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Apoptosis in human diseases: role of Fas system in liver cell injury by viral hepatitis].
    Mita E; Hayashi N
    Rinsho Byori; 1997 May; 45(5):477-82. PubMed ID: 9170976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Fas antigen on hepatocytes in viral hepatitis patients.
    Sekine K; Nishimaki T; Suzuki T; Kasukawa R
    Fukushima J Med Sci; 1997 Jun; 43(1):51-9. PubMed ID: 9431784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of the fas system in hepatitis C virus recurrence after liver transplantation.
    Crespo J; Rivero M; Mayorga M; Fabrega E; Casafont F; Gomez-Fleitas M; Pons-Romero F
    Liver Transpl; 2000 Sep; 6(5):562-9. PubMed ID: 10980054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical detection of Fas and apoptosis in type-1 autoimmune hepatitis.
    Seki S; Kitada T; Iwai S; Kadoya H; Yamada T; Kawada N; Sakaguchi H; Wakasa K
    Hepatogastroenterology; 2003; 50(53):1274-7. PubMed ID: 14571717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis in acute hepatic failure: histopathological study of human liver tissue using the tunel method and immunohistochemistry.
    Kasahara I; Saitoh K; Nakamura K
    J Med Dent Sci; 2000 Sep; 47(3):167-75. PubMed ID: 12160229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [An immunohistochemical analysis in portal lymphocytic aggregation of chronic hepatitis C].
    Tsuno S; Zeniya M
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):635-41. PubMed ID: 7563846
    [No Abstract]   [Full Text] [Related]  

  • 13. Expression of Fas ligand by hepatic macrophages in patients with fulminant hepatic failure.
    Mita A; Hashikura Y; Tagawa Y; Nakayama J; Kawakubo M; Miyagawa S
    Am J Gastroenterol; 2005 Nov; 100(11):2551-9. PubMed ID: 16279913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased hepatocyte fas expression and apoptosis in HIV and hepatitis C virus coinfection.
    Macias J; Japón MA; Sáez C; Palacios RB; Mira JA; García-García JA; Merchante N; Vergara S; Lozano F; Gómez-Mateos J; Pineda JA
    J Infect Dis; 2005 Nov; 192(9):1566-76. PubMed ID: 16206071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of in vivo blockade of Fas- and TNFR1-mediated hepatocyte apoptosis by the hepatitis C virus.
    Rubbia-Brandt L; Taylor S; Gindre P; Quadri R; Abid K; Spahr L; Negro F
    J Pathol; 2002 Aug; 197(5):617-23. PubMed ID: 12210081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic hepatitis C. Analysis of host immune response by immunohistochemistry.
    Marrogi AJ; Cheles MK; Gerber MA
    Arch Pathol Lab Med; 1995 Mar; 119(3):232-7. PubMed ID: 7534056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perforin, Fas/Fas ligand, and TNF-alpha pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL.
    Ando K; Hiroishi K; Kaneko T; Moriyama T; Muto Y; Kayagaki N; Yagita H; Okumura K; Imawari M
    J Immunol; 1997 Jun; 158(11):5283-91. PubMed ID: 9164947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical detection of hepatitis C virus related C100-3 and core antigens in formalin-fixed liver tissue.
    Chamlian A; Benkoël L; Sahel J; Cherid A; Brisse J; Ikoli JF; Lambert R; De Lamballerie X
    Cell Mol Biol (Noisy-le-grand); 1996 Jun; 42(4):557-66. PubMed ID: 8828911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis and pathogenesis of viral hepatitis C--an update.
    Nasir A; Arora HS; Kaiser HE
    In Vivo; 2000; 14(1):297-300. PubMed ID: 10757089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative correlation between intrahepatic expression of hepatitis C antigens and apoptosis despite high-level expression of Fas and HLA antigens.
    Caronia S; McGarvey MJ; Goldin RD; Foster GR
    J Viral Hepat; 2004 Nov; 11(6):511-8. PubMed ID: 15500551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.